РусскийEnglish (UK)
     
 

Публикации с 2016 года

Кол-во строк: 
# Заголовок
21 Carbohydrate composition of circulating multiple-modified low-density lipoprotein.

Zakiev ER1, Sobenin IA2, Sukhorukov VN1, Myasoedova VA1, Ivanova EA3, Orekhov AN4.
Vasc Health Risk Manag. 2016 Oct 14;12:379-385. eCollection 2016.

22 Epigenetically active drugs inhibiting DNA methylation and histone deacetylation.

Chistiakov DA, Myasoedova VA, Orekhov AN, Bobryshev YV.
Curr Pharm Des. 2016 Oct 21. [Epub ahead of print]

23 Mutations of mitochondrial DNA in chronic non-inflammatory diseases: target candidates for treatment.

Galitsyna EV, Sazonova MA, Shkurat TP, Demakova NA, Melnichenko AA, Sinyov VV, Ryzhkova AI, Mitrofanov KY, Zhelankin AV, Sobenin IA, Orekhov AN.

Curr Pharm Des. 2016 Oct 18. [Epub ahead of print]

24 Sialidases: Therapeutic And Antiatherogenic Potential.

Sukhorukov VN, Karagodin VP, Zakiev ER, Orekhov AN.
Curr Pharm Des. 2016 Oct 19. [Epub ahead of print]

25 Paraoxonase and atherosclerosis-related cardiovascular diseases

Chistiakov DA, Melnichenko AA, Orekhov AN, Bobryshev YV.
Biochimie. 2016 Oct 19. pii: S0300-9084(16)30284-X. doi: 10.1016/j.biochi.2016.10.010. [Epub ahead of print]

26 PPAR Agonists, Atherogenic Dyslipidemia and Cardiovascular Risk.

Nikolic D, Castellino G, Banach M, Toth PP, Ivanova E, Orekhov AN, Montalto G, Rizzo M.
Curr Pharm Des. 2016 Oct 6. [Epub ahead of print]

27 Mutations of nuclear and mitochondrial genomes as potential targets for the treatment of metabolic syndrome.

Galitsyna EV, Zhelankin AV, Sobenin IA, Orekhov AN.
Curr Pharm Des. 2016 Oct 18. [Epub ahead of print]

28 The role of cardiac fibroblasts in post-myocardial heart tissue repair.

Chistiakov DA, Orekhov AN, Bobryshev YV.
Exp Mol Pathol. 2016 Sep 9;101(2):231-240. doi: 10.1016/j.yexmp.2016.09.002. [Epub ahead of print]

29 [Atherogenic modification of low-density lipoproteins]

Sukhorukov VN, Karagodin VP, Orekhov AN.

Biomed Khim. 2016 May;62(4):391-402. doi: 10.18097/PBMC20166204391.

30 Lipid composition of circulating multiple-modified low density lipoprotein.

Zakiev ER, Sukhorukov VN, Melnichenko AA, Sobenin IA, Ivanova EA, Orekhov AN.

Lipids Health Dis. 2016 Aug 24;15(1):134. doi: 10.1186/s12944-016-0308-2.